KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Revenue (2016 - 2025)

Petmed Express' Revenue history spans 16 years, with the latest figure at $40.7 million for Q4 2025.

  • For Q4 2025, Revenue fell 21.75% year-over-year to $40.7 million; the TTM value through Dec 2025 reached $187.0 million, down 22.51%, while the annual FY2025 figure was $227.0 million, 17.19% down from the prior year.
  • Revenue reached $40.7 million in Q4 2025 per PETS's latest filing, down from $44.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $78.8 million in Q2 2021 to a low of $40.7 million in Q4 2025.
  • Average Revenue over 5 years is $61.4 million, with a median of $63.4 million recorded in 2022.
  • Peak YoY movement for Revenue: grew 12.65% in 2023, then decreased 23.57% in 2025.
  • A 5-year view of Revenue shows it stood at $60.6 million in 2021, then dropped by 5.51% to $57.2 million in 2022, then increased by 11.24% to $63.7 million in 2023, then decreased by 18.39% to $52.0 million in 2024, then dropped by 21.75% to $40.7 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Revenue are $40.7 million (Q4 2025), $44.4 million (Q3 2025), and $51.2 million (Q2 2025).